Key result
Endothelial dysfunction and smooth muscle hyperreactivity drive coronary artery spasm, with smoking the primary modifiable risk.
Why the study?
Coronary artery spasm is underrecognized due to limited access to pharmacological provocation testing, and its distinct risk profile and mechanisms require synthesis to improve phenotype-informed risk stratification and precision management.
This review provides an integrated framework of the mechanisms and risk factors for coronary artery spasm, emphasizing the need for phenotype-informed precision management in patients with INOCA and MINOCA.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Supports provocation testing for CAS in INOCA/MINOCA; extends mechanistic models but leaves open phenotype-specific trials.
Coronary artery spasm (CAS) is a major form of coronary vasomotor dysfunction within ischemia with non-obstructive coronary arteries (INOCA). Despite ethnic and geographic variation in prevalence, CAS is underrecognized because confirmation often requires pharmacological provocation testing that is unavailable in many centers. Clinically, CAS ranges from silent ischemia and angina to acute myocardial infarction, malignant arrhythmias, heart failure, and sudden cardiac death. Evidence suggests that spasm often occurs at sites with mild atherosclerosis and that its risk profile differs from atherosclerotic cardiovascular disease, with more consistent links to smoking, inflammatory burden, and genetic susceptibility, while associations with hypertension and diabetes remain inconsistent. Advances in invasive coronary function testing and recognition of microvascular spasm support an integrated framework involving endothelial dysfunction, vascular smooth muscle hyperreactivity, inflammation–oxidative stress, and autonomic dysregulation. This review synthesizes mechanistic and clinical evidence across these domains, highlights translational opportunities for phenotype-informed risk stratification and precision management, and outlines key research priorities to improve CAS care.
Kuang et al. (2026) conducted a review in Coronary artery spasm (CAS). Coronary artery spasm is a multifactorial vasomotor disorder driven by endothelial dysfunction and vascular smooth muscle hyperreactivity, with smoking as the most established modifiable risk factor.
Synapse has enriched 10 related papers. Consider them for comparative context: